Document:

sbbp_Ex_1018

		
			Exhibit 10.18
		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			RESTRICTED STOCK UNIT AWARD
		

		
			Strongbridge Biopharma plc (the “Company”) has determined to grant to you an award of restricted stock units (the “RSUs”) under the 2015 Equity Compensation Plan (the “Plan”).  The terms of the grant are set forth in the attached Restricted Stock Unit Award Agreement (the “Agreement”).  The following provides a summary of the key terms of the Agreement; however, you should read the entire Agreement along with the terms of the Plan, to fully understand the Agreement.
		

		
			 
		

		
			SUMMARY OF RESTRICTED STOCK UNIT AWARD
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Grantee:

					
					
						[name]

				
	
					
						Date of Grant:

					
					
						[date]

				
	
					
						Vesting Schedule:

					
					
						100% vest on 2-year anniversary of Date of Grant (provided employee is employed by the Company on such vesting date)

				
	
					
						Total Number of Restricted Stock Units Granted:

					
					
						[#units]

				

		
			 
		

		
			 
		

		
			 
		

		
			

		 

 

		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			RESTRICTED STOCK UNIT AWARD AGREEMENT
		

		
			This RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Agreement”), dated as of [DATE], (the “Date of Grant”) is delivered by Strongbridge Biopharma plc (the “Company”), to [NAME] (the “Grantee”).  
		

		
			The Company has determined to provide the Grantee an award of restricted stock units under the 2015 Equity Compensation Plan (the “Plan”) and in accordance with the terms and conditions set forth in this Agreement.  Capitalized terms that are used but not defined herein shall have the respective meanings accorded to such terms in the Plan.
		

		
			The Plan is administered and interpreted by the Compensation Committee of the Board of Directors of the Company (the “Board”) (or a subcommittee thereof), or such other committee of the Board (including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of the Plan (the “Committee”). The Committee may delegate authority to one or more subcommittees as it deems appropriate. If a subcommittee is appointed, all references in this Agreement to the “Committee” shall be deemed to refer to the committee.    
		

		
			The Company and Grantee, intending to be legally bound hereby, agree as follows:
		

		
			1.         Grant of Restricted Stock Unit Award.  Subject to the terms and conditions set forth in this Agreement and the Plan, the Company hereby awards to the Grantee [#units] Restricted Stock Units (the “RSUs”) under the Plan.  The Grantee accepts the RSUs and agrees to be bound by the terms and conditions of this Agreement and the Plan with respect to the award. Each vested RSU entitles the Grantee to receive one share of Company Stock, as described in Paragraph 2 below.
		

		
			2.         Vesting of Award/Payment of Shares.
		

		
			(a)        The RSUs shall vest in full on the second anniversary of the Date of Grant (the “Vesting Date”), if the Grantee continues to be employed by, or provide service to, the Company (or its parent or subsidiary, as applicable) (the “Employer”) from the Date of Grant until the Vesting Date.
		

		
			(b)        If and when the RSUs vest, the Company will issue to the Grantee one share of Company Stock for each whole RSU that has vested, subject to satisfaction of the Grantee’s tax withholding obligations as described in Paragraph 5 below.  The RSUs shall cease to be outstanding upon such issuance of shares.
		

		
			(c)        Unless otherwise provided in a Company-sponsored plan, policy or arrangement, or any agreement to which the Employer is a party, the Grantee shall forfeit the unvested RSUs in 
		

		
			
		

		
			

		 

		

			 

		

 

		

		
			the event the Grantee ceases to be employed by, or provide service to, the Employer prior to the Vesting Date.
		

		
			3.         No Stockholder Rights Prior to Settlement; Issuance of Certificates. The Grantee shall have no rights as a stockholder with respect to any shares of Company Stock represented by the RSUs until the date of issuance of the shares of Company Stock (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), if applicable.  Except as otherwise required by the Plan, no adjustment shall be made for dividends, distributions, or other rights for which the record date is prior to the date, if any, that shares of Company Stock are issued.
		

		
			4.         Change of Control.  Upon a Change of Control (as defined in the Plan), the RSUs shall accelerate and vest and shall be paid pursuant to Paragraph 2(b) above, provided that the Grantee is employed by, or providing service to, the Employer on the date of such Change of Control.  
		

		
			5.         Withholding.  The Grantee shall be required to pay to the Company, or make other arrangements satisfactory to the Company to provide for the payment of, any federal, state, local or other taxes that the Employer is required to withhold with respect to the grant or vesting of the RSUs, or the Employer may deduct from other wages paid by the Employer the amount of any withholding taxes due with respect to the RSUs. The Grantee may elect to satisfy any income tax withholding obligation of the Employer with respect to the RSUs by having shares of Company Stock withheld up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state, local and other tax liabilities. Unless the tax withholding obligations of the Company are satisfied, the Company shall have no obligation to deliver to the Grantee any Company Stock.  In the event the Company’s obligation to withhold arises prior to the delivery to the Grantee of shares of Company Stock or it is determined after the delivery of shares of Company Stock to the Grantee that the amount of the Company’s withholding obligation was greater than the amount withheld by the Company, the Grantee agrees to indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount.
		

		
			6.         Adjustments.  The provisions of the Plan applicable to adjustments (as described in Section 3 of the Plan) shall apply to the RSUs.
		

		
			7.         Assignment and Transfers.  The rights and interests of the Grantee under this Agreement may not be sold, assigned, encumbered or otherwise transferred except, in the event of the death of the Grantee, by will or by the laws of descent and distribution.  In the event of any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose of the RSUs or any right hereunder, or in the event of the levy or any attachment, execution or similar process upon the rights or interests hereby conferred, the Company may terminate the RSUs by notice to the Grantee, and the RSUs and all rights hereunder shall thereupon become null and void.  The rights and protections of the Company hereunder shall extend to any successors or assigns of the Company and to the Company’s parents, subsidiaries, and affiliates.  This Agreement may be assigned by the Company without the Grantee’s consent.
		

		
			
		

		
			

		 

		

			-  2  -

		

 

		

		
			8.         Miscellaneous.
		

		
			(a)        No Right to Employment.  The grant of the RSUs shall not be construed as giving the Grantee the right to be retained by or in the employ of the Employer or any other employment right.
		

		
			(b)        Delivery Subject to Legal Requirements. The obligation of the Company to deliver stock shall be subject to the condition that if at any time the Board shall determine in its discretion that the listing, registration or qualification of the shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issue of shares, the shares may not be issued in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board.  The issuance of shares to the Grantee pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States or of any state having jurisdiction thereof.
		

		
			(c)        RSUs Subject to Plan.  By entering into this Agreement the Grantee agrees and acknowledges that the Grantee has received and read a copy of the Plan.  The RSUs are subject to the terms and provisions of the Plan, as they may be amended from time to time, and such terms and provisions of the Plan are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.
		

		
			(d)        Committee Authority.  By entering into this Agreement the Grantee agrees and acknowledges that all decisions and determinations of the Committee shall be final and binding on the Grantee, his or her beneficiaries and any other person having or claiming and interest in the RSUs.
		

		
			(e)        Severability.  If any provision of this Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction or would disqualify this Agreement or the RSUs under any applicable law, such provision shall be construed or deemed amended to conform to applicable law (or if such provision cannot be so construed or deemed amended without materially altering the purpose or intent of this Agreement and the grant of the RSUs hereunder, such provision shall be stricken as to such jurisdiction and the remainder of this Agreement and the award shall remain in full force and effect).
		

		
			(d)        Notices.  Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company, at the attention of the Committee, at its principal place of business, and any notice to be given to Grantee may be sent to Grantee’s address as it appears in the payroll records of the Company, or at such other addresses as either party may designate in writing to the other.
		

		
			(e)        Section 409A.  This Agreement and the RSUs granted hereunder are intended to fit within the “short-term deferral” exemption from Section 409A of the Code, as set forth in Treasury Regulation Section 1.409A-1(b)(4) or any successor provision, or to comply with, or otherwise be exempt from, Section 409A of the Code.  This Agreement and the RSUs shall be administered, interpreted and construed in a manner consistent with Section 409A of the Code.  Each amount 
		

		
			
		

		
			

		 

		

			-  3  -

		

 

		

		
			payable under this Agreement is designated as a separate identified payment for purposes of Section 409A of the Code.  The payment of dividend equivalents under Paragraph 3 of this Agreement shall be construed as earnings and the time and form of payment of such dividend equivalents shall be treated separately from the time and form of payment of the underlying RSUs for purposes of Section 409A of the Code.
		

		
			(f)        Governing Law. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions thereof
		

		
			(g)        Interpretation.  The Grantee accepts the RSUs subject to all the terms and provisions of this Agreement and the terms and conditions of the Plan.
		

		
			(g)        Headings.  Headings are given to the paragraphs and subparagraphs of this Agreement solely as a convenience to facilitate reference.  Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Agreement or any provision thereof.
		

		
			(h)        Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement.  Facsimile or other electronic transmission of any signed original document or retransmission of any signed facsimile or other electronic transmission will be deemed the same as delivery of an original.
		

		
			(i)         Complete Agreement.  Except as otherwise provided for herein, this Agreement and those agreements and documents expressly referred to herein embody the complete agreement and understanding among the parties and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way.  The terms of this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Grantee.
		

		
			 
		

		
			 
		

		
			[Signature Page Follows]
		

		
			 
		

		
			 
		

		
			

		 

		

			-  4  -

		

 

		

		
			IN WITNESS WHEREOF, the Company and Grantee have executed this Agreement as of the grant date shown above.
		

			
					
						 

					
					
						Strongbridge Biopharma plc

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						By:

					
					
						 

				
	
					
						 

					
					
						Name:

					
					
						Matthew Pauls

				
	
					
						 

					
					
						Title:

					
					
						Chief Executive Officer

				
	
					
						 

					
					
						 

				

		
			 
		

		
			I hereby accept the RSUs described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement.  I hereby further agree that all the decisions and determinations of the Committee shall be final and binding.
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						GRANTEE:

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						Name:

					
					
						[name]

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						Date:

					
					
						 

				
	
					
						 

					
					
						 

				

		
			 
		

		 

		

			(Signature Page to Restricted Stock Unit Award Agreement)sbbp_Ex_1019

		
			Exhibit 10.19
		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLAN
		

		
			NONQUALIFIED STOCK OPTION AWARD
		

		
			Strongbridge Biopharma plc (the “Company”) has granted you a Stock Option (the “Option”) under the Non-Employee Director Equity Compensation Plan (the “Plan”).  The terms of the grant are set forth in the Stock Option Award Agreement provided to you (the “Agreement”).  The following provides a summary of the key terms of the grant; however, you should read the entire Agreement, along with the terms of the Plan, to fully understand the grant.
		

		
			 
		

		
			SUMMARY OF NONQUALIFIED STOCK OPTION AWARD
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Grantee:

					
					
						[name]

				
	
					
						Date of Grant:

					
					
						[date]

				
	
					
						Vesting Schedule:

					
					
						To vest and become exercisable (i) on [date], provided that the applicable member of the Board continues to provide service as a member of the Board continuously from the date of grant through [date]; (ii) upon a change of control of the Company, provided the applicable member of the Board is a director of the Company on such date.

				
	
					
						Exercise Price Per Share:

					
					
						[price]

				
	
					
						Total Number of Options Granted:

					
					
						[#units]

				
	
					
						Term/Expiration Date:

					
					
						[date]

				

		
			 
		

		
			
		

		
			

		 

		

			

		

 

		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLAN
		

		
			NONQUALIFIED STOCK OPTION AWARD AGREEMENT
		

		
			This STOCK OPTION AWARD AGREEMENT (the “Agreement”), dated as of [date] (the “Date of Grant”), is delivered by Strongbridge Biopharma plc (the “Company”) to [name] (the “Grantee”).
		

		
			RECITALS
		

		
			A.The Non-Employee Director Equity Compensation Plan (the “Plan”) provides for the grant of options to purchase shares of common stock of the Company (“Company Stock”). The Company has decided to make a stock option award as an inducement for the Grantee to promote the best interests of the Company and its stockholders. Capitalized terms that are used but not defined herein shall have the respective meanings accorded to such terms in the Plan.  
		

		
			B.The Plan is administered and interpreted by the Board of Directors of the Company (the “Board”). 
		

		
			NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:
		

			
	
			
				 1.
			Grant of Option.  Subject to the terms and conditions set forth in this Agreement and in the Plan, the Company hereby grants to the Grantee a Stock Option (the “Option”) to purchase ___________ shares of Company Stock at an exercise price of $[____] per share.

			
	
			
				 2.
			Vesting.  The Option shall become vested and exercisable, according to the following vesting schedule, if the Grantee continues to provide service to the Company from the Date of Grant until the applicable vesting date:

			
					
						Vesting Date

					
					
						% of Option Vested 

				
	
					
						To vest and become exercisable (i) on [date], provided that the applicable member of the Board continues to provide service as a member of the Board continuously from the date of grant through [date]; (ii) upon a change of control of the Company, provided the applicable member of the Board is a director of the Company on such date.

					
					
						100%

				

		
			 
		

		
			The vesting of the Option shall be cumulative, but shall not exceed 100% of the shares subject to the Option granted above.  If the foregoing schedule would produce fractional shares, the portion of the Option that vests shall be rounded down to the nearest whole share.
		

		
			

		 

		

			-  1  -

		

 

		

			
	
			
				 3.
			Term of Option.

			
	
			
				 (a)
			The Option shall have a term of ten (10) years from the Date of Grant and shall terminate at the expiration of that period, unless it is terminated at an earlier date pursuant to the provisions of this Agreement or the Plan.

			
	
			
				 (b)
			Unless a later termination date is provided for in a Company-sponsored plan, policy or arrangement, or any agreement to which the Company is a party, the Option shall automatically terminate upon the happening of the first of the following events:

			
	
			
				 (i)
			The expiration of the ninety (90) day period after the Grantee ceases to provide service to the Company, if the termination is for any reason other than Disability (as defined in the Plan), death or Cause (as defined in the Plan).

			
	
			
				 (ii)
			The expiration of the one (1) year period after the Grantee ceases to provide service to the Company on account of the Grantee’s Disability.

			
	
			
				 (iii)
			The expiration of the one (1) year period after the Grantee ceases to provide service to the Company, if the Grantee dies (x) while providing service to the Company or (y) within ninety (90) days after the Grantee ceases to provide such services on account of a termination described in subparagraph (i) above.

			
	
			
				 (iv)
			The date on which the Grantee ceases to provide service to the Company on account of a removal for Cause.  In addition, notwithstanding the prior provisions of this Paragraph 3, if a majority of disinterested members of the Board determines that the Grantee has engaged in conduct that constitutes Cause at any time while the Grantee is providing service to the Company or after the Grantee’s termination of service, any Option held by the Grantee shall immediately terminate, and the Grantee shall automatically forfeit all shares underlying any exercised portion of an Option for which the Company has not yet delivered the share certificates, upon refund by the Company of the Exercise Price paid by the Grantee for such shares.

		
			Notwithstanding the foregoing, in no event may the Option be exercised after the date that is immediately before the tenth anniversary of the Date of Grant.  Any portion of the Option that is not vested and exercisable at the time the Grantee ceases to provide service to the Company shall immediately terminate.
		

		
			 
		

			
	
			
				 4.
			Exercise Procedures

			
	
			
				 (a)
			Subject to the provisions of Paragraphs 2 and 3 above, the Grantee may exercise part or all of the vested Option by delivering a written notice of exercise to the Company in the manner provided in this Agreement, specifying the number of shares of Company Stock as to which the Option is to be exercised.  The Grantee shall pay the Exercise Price (i) in cash, (ii) by delivering shares of Company Stock owned by the Grantee (including Company Stock acquired in connection with the exercise of an Option, subject to such restrictions as the Board deems appropriate) and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation (on a form prescribed by the Board) to ownership of shares of Company Stock having a Fair Market Value on the date of exercise equal to the Exercise Price; (iii) after a Public Offering, 

		 

		

			-  2  -

		

 

	by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board; or (iv) by such other method as the Board may approve.  In addition, the Grantee may elect to settle the Option on a “net basis” by taking delivery of the number of Company Stock equal to Fair Market Value of the shares subject to any Option less the exercise price, any tax (or governmental obligation) or other administration fees due. The Company may impose from time to time such limitations as it deems appropriate on the use of shares of  Company Stock to exercise the Option.  

			
	
			
				 (b)
			The obligation of the Company to deliver shares of Company Stock upon exercise of the Option shall be subject to all applicable laws, rules, and regulations and such approvals by governmental agencies as may be deemed appropriate by the Company, including such actions as Company counsel shall deem necessary or appropriate to comply with relevant securities laws and regulations.  The Company may require that the Grantee (or other person exercising the Option after the Grantee’s death) represent that the Grantee is purchasing shares of Company Stock for the Grantee’s own account and not with a view to or for sale in connection with any distribution of the shares of Company Stock, or such other representation as the Company deems appropriate.  

			
	
			
				 5.
			Change of Control.  Upon a Change of Control (as defined in the Plan), the Option shall automatically accelerate and become fully vested and exercisable, provided that the Grantee is providing service to the Company on the date of such Change of Control.

			
	
			
				 6.
			Restrictions on Exercise.  Except as the Company may otherwise permit pursuant to the Plan, only the Grantee may exercise rights under the Option during the Grantee’s lifetime and, after the Grantee’s death, the Option shall be exercisable (subject to the limitations specified in the Plan) solely by the personal representative or other person entitled to succeed to the rights of the Grantee, or by the person who acquires the right to exercise the Option by will or by the laws of descent and distribution, or if permitted in any case by the Board, pursuant to a domestic relations order or otherwise as permitted by the Board, to the extent that the Option is vested and exercisable pursuant to this Agreement. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Option under the Grantee’s will or under the applicable laws of descent and distribution. 

			
	
			
				 7.
			Adjustments.  The provisions of the Plan applicable to Adjustments (as described in Section 3 of the Plan) shall apply to the Option.

			
	
			
				 8.
			Grant Subject to Plan Provisions.  This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan.  The grant and exercise of the Option are subject to interpretations, regulations and determinations concerning the Plan established from time to time by the Board in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and obligations with respect to withholding taxes, (ii) the registration, qualification or listing of the shares of Company Stock, (iii) changes in capitalization of the Company and (iv) other requirements of applicable law.  The Board shall have the authority to interpret and construe the Option pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.

		
			

		 

		

			-  3  -

		

 

		

			
	
			
				 9.
			No Rights to Conitnued Service.  The grant of the Option shall not confer upon the Grantee any right to be retained by or in the service of the Company and shall not interfere in any way with the right of the Board to terminate the Grantee’s service.  

			
	
			
				 10.
			No Shareholder Rights.  Neither the Grantee, nor any person entitled to exercise the Grantee’s rights in the event of the Grantee’s death, shall have any of the rights and privileges of a shareholder with respect to the shares of Company Stock subject to the Option, until certificates for shares of Company Stock have been issued upon the exercise of the Option.

			
	
			
				 11.
			Assignment and Transfers.  Except as the Board may otherwise permit pursuant to the Plan, the rights and interests of the Grantee under this Agreement may not be sold, assigned, encumbered or otherwise transferred except, in the event of the death of the Grantee, by will or by the laws of descent and distribution or if permitted in any specific case by the Board, pursuant to a domestic relations order or otherwise as permitted by the Board. In the event of any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose of the Option or any right hereunder, except as provided for in this Agreement, or in the event of the levy or any attachment, execution or similar process upon the rights or interests hereby conferred, the Company may terminate the Option by notice to the Grantee, and the Option and all rights hereunder shall thereupon become null and void.  The rights and protections of the Company hereunder shall extend to any successors or assigns of the Company and to the Company’s parents, subsidiaries, and affiliates.  This Agreement may be assigned by the Company without the Grantee’s consent.

			
	
			
				 12.
			Applicable Law.  The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of laws provisions thereof.

			
	
			
				 13.
			Notice.  Any notice to the Company provided for in this Agreement shall be addressed to the Company in care of the Board, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of the Company, or to such other address as the Grantee may designate to the Company in writing.  

		
			 
		

		
			

		 

		

			-  4  -

		

 

		

		
			IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute this Agreement, and the Grantee has executed this Agreement, effective as of the Date of Grant.
		

		
			 
		

		
			Strongbridge Biopharma plc
		

		
			 
		

		
			By:Name: Matthew Pauls
		

		
			Title: Chief Executive Officer
		

		
			 
		

		
			 
		

		
			I hereby accept the Option described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement.  I hereby further agree that all the decisions and determinations of the Board shall be final and binding.
		

		
			 
		

		
			 
		

		
			Grantee:
		

		
			 
		

		
			 
		

		
			
		

		
			Name:  [name]
		

		
			Date:
		

		 

		

			(Signature Page to Nonqualified Stock Option Award Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}]]